Synthetic Biologics (SYN) Seen as Undervalued at RBC Capital

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. CRWD
2. AAPL
3. LITE
4. PLTR
5. REGN
6. MRVL
7. ABBV
8. CL
9. CHKP
10. SPY

Go back to Synthetic Biologics (SYN) Seen as Undervalued at RBC Capital

Synthetic Biologics (SYN) Announces Second SYN-010 Phase 2 in IBS-C Met Primary Endpoint

January 19, 2016 4:35 PM EST

Synthetic Biologics, Inc. (NYSE: SYN) reported that the second Phase 2 clinical trial of its proprietary SYN-010 for the treatment of irritable bowel syndrome with constipation (IBS-C) met its primary... More